DENTSPLY SIRONA (NASDAQ:XRAY) PT Lowered to $47.00

DENTSPLY SIRONA (NASDAQ:XRAYGet Rating) had its price target decreased by analysts at The Goldman Sachs Group from $59.00 to $47.00 in a report released on Thursday, Marketbeat.com reports. The brokerage currently has a “neutral” rating on the medical instruments supplier’s stock. The Goldman Sachs Group’s price target indicates a potential upside of 14.77% from the stock’s current price.

XRAY has been the subject of a number of other research reports. Piper Sandler reiterated a “neutral” rating and set a $46.00 target price (down previously from $71.00) on shares of DENTSPLY SIRONA in a research report on Wednesday. William Blair cut shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Tuesday. StockNews.com lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Wednesday. Barrington Research reduced their price objective on shares of DENTSPLY SIRONA from $72.00 to $53.00 in a research note on Wednesday. Finally, TheStreet lowered shares of DENTSPLY SIRONA from a “b-” rating to a “c+” rating in a research note on Friday, March 18th. Seven research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $53.11.

NASDAQ XRAY opened at $40.95 on Thursday. The company has a current ratio of 1.55, a quick ratio of 1.12 and a debt-to-equity ratio of 0.38. DENTSPLY SIRONA has a 1 year low of $40.65 and a 1 year high of $69.54. The company has a fifty day simple moving average of $50.23 and a 200 day simple moving average of $53.05. The company has a market cap of $8.82 billion, a P/E ratio of 21.33, a P/E/G ratio of 1.57 and a beta of 0.86.

DENTSPLY SIRONA (NASDAQ:XRAYGet Rating) last issued its quarterly earnings results on Monday, February 28th. The medical instruments supplier reported $0.76 earnings per share for the quarter, missing analysts’ consensus estimates of $0.79 by ($0.03). DENTSPLY SIRONA had a net margin of 9.90% and a return on equity of 12.51%. The company had revenue of $1.09 billion during the quarter, compared to the consensus estimate of $1.13 billion. During the same period last year, the company earned $0.87 earnings per share. DENTSPLY SIRONA’s revenue for the quarter was up .6% on a year-over-year basis. Equities research analysts forecast that DENTSPLY SIRONA will post 3.1 EPS for the current fiscal year.

Several institutional investors have recently made changes to their positions in the company. BlackRock Inc. boosted its position in shares of DENTSPLY SIRONA by 4.2% in the fourth quarter. BlackRock Inc. now owns 17,700,553 shares of the medical instruments supplier’s stock valued at $987,514,000 after acquiring an additional 709,095 shares during the period. Artisan Partners Limited Partnership boosted its position in shares of DENTSPLY SIRONA by 0.4% in the third quarter. Artisan Partners Limited Partnership now owns 11,383,822 shares of the medical instruments supplier’s stock valued at $660,831,000 after acquiring an additional 46,064 shares during the period. First Eagle Investment Management LLC boosted its position in shares of DENTSPLY SIRONA by 16.5% in the fourth quarter. First Eagle Investment Management LLC now owns 7,184,012 shares of the medical instruments supplier’s stock valued at $400,796,000 after acquiring an additional 1,018,179 shares during the period. Champlain Investment Partners LLC lifted its position in DENTSPLY SIRONA by 15.6% during the fourth quarter. Champlain Investment Partners LLC now owns 5,436,245 shares of the medical instruments supplier’s stock worth $303,288,000 after purchasing an additional 733,144 shares during the period. Finally, Invesco Ltd. lifted its position in DENTSPLY SIRONA by 12.2% during the fourth quarter. Invesco Ltd. now owns 4,452,530 shares of the medical instruments supplier’s stock worth $248,406,000 after purchasing an additional 482,532 shares during the period. 97.32% of the stock is owned by institutional investors.

DENTSPLY SIRONA Company Profile (Get Rating)

DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces.

Further Reading

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.